Health
Ozempic-Class Drug Keeps Appetite Suppressed More Than a Year, Penn Study Finds
A 60-week trial found people on semaglutide were still eating 24 to 30 percent fewer calories than a placebo group a year in, helping explain why the weight loss holds up long after the drug's initial hunger-killing effect fades.
2h ago